chemoradiotherapy

chemoradiotherapy

 
combined modality therapy using chemotherapy and radiotherapy, designed to reduce the need for surgery by maximizing the interaction between the radiation and the therapeutic agent or agents.

chemoradiotherapy

/che·mo·ra·dio·ther·a·py/ (-ra″de-o-ther´ah-pe) combined modality therapy using chemotherapy and radiotherapy, maximizing their interaction.

chemoradiotherapy

combined modality therapy using chemotherapy and radiotherapy, designed to reduce the need for surgery by maximizing the interaction between the radiation and the therapeutic agent or agents.

chemoradiation

Chemotherapeutics—e.g., 5-FU, cisplatin, etoposide—followed by radiation therapy to treat cancer.

che·mo·ra·di·o·ther·a·py

(kē'mō-rā'dē-ō-thār'ă-pē)
A treatment plan that combines chemotherapy and radiotherapy.
References in periodicals archive ?
Genelux Corporation, a clinical-stage biopharmaceutical company developing vaccinia virus-based oncolytic (cancer-killing) therapies and companion diagnostics for cancer, has announced today that the first patient has been medicated in a Phase I clinical trial of GL-ONC1 combined with chemoradiotherapy in patients with locoregionally advanced head and neck cancers.
The primary breast tumour had been resected three years previously and adjuvant chemoradiotherapy had been administered at the time.
2) Immunohistochemistry is mandatory for diagnosis, and ideal treatment includes radical surgery and chemoradiotherapy.
Patients frequently are unable to afford the daily transportation costs imposed by concurrent chemoradiotherapy programs.
Focusing on treatment strategies like chemotherapy, concurrent chemoradiotherapy, and sequential chemoradiotherapy, an international group of oncologists and surgeons also discuss biologic and targeted therapies, radiation therapy, the role of human papillomavirus (HPV) infections in oropharynx cancer, nuclear imaging, advances in nasopharyngeal and thyroid cancers, new surgical techniques including robotic and minimally invasive surgery, and the evaluation and treatment of dysphagia and aspiration.
The chapter on Stage III: Definitive Chemoradiotherapy reviews the optimization of combined radiotherapy and chemotherapy with a good discussion on trials using the sequential and concurrent approach, the optimal regimens to be used, and the influence of co-morbidities on outcome.
Patients who receive combined chemoradiotherapy have an increased median survival time compared with patients who receive either stenting or brachytherapy alone.
Malone, of the Southern Illinois School of Medicine, Springfield has suggested that imaging tests conducted six to eight weeks after patients complete chemoradiotherapy for head and neck cancer may help identify patients who will respond to treatment and those who will require surgical follow-up.
The largest trial to evaluate the role of chemoradiotherapy as adjuvant treatment was the US Intergroup 0116.
Current treatment options include surgery, radiation therapy and/or concurrent chemoradiotherapy.
The articles on gastrointestinal surgery address such issues as bariatric surgery, neoadjuvant chemoradiotherapy for pancreatic cancer, neoplasms of the pancreas, stomal tumors, imaging, laparascopic surgery and treatment for rectal tumors.
Patients with stage III non-small cell lung cancer did not live longer when researchers added AE-941 (Neovastat), a shark cartilage extract, to standard chemoradiotherapy in a 53-site phase III trial presented at the annual meeting of the American Society of Clinical Oncology.